Inventaire - dina vänner och gemenskaper är ditt bästa bibliotek

Treatment-refractory anxiety; definition, risk factors, and treatment challenges

författare

Peter Roy-Byrne

publicerad i: Dialogues in Clinical Neuroscience

utgivningsår: 2015-06-01

språk: engelska

huvudämne: ångest, anxiolytika, kognitiv beteendeterapi

Refererar artiklar 115

Datum

Titel

Författare

2015-02-13

Is Exposure Necessary? A Randomized Clinical Trial of Interpersonal Psychotherapy for PTSD

Eva Petkova, Yihong Zhao, Karina Lovell, Elizabeth A. Hembree
2014-04

Critical review of outcome research on interpersonal psychotherapy for anxiety disorders
2014-01-01

The Future of D-Cycloserine and Other Cognitive Modifiers in Obsessive-Compulsive and Related Disorders

Eric A Storch, Tanya Murphy
2014-09-01

Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine

Mark J Niciu, Carlos A Zarate Jr, Nancy E Brutsche, David A Luckenbaugh, Erica M Richards, Dawn F Ionescu, Jennifer L Vande Voort, Elizabeth E Slonena
2014-09-08

Psychomotor agitation in major depressive disorder is a predictive factor of mood-switching

Heii Arai
2014-01-01

A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder

Elizabeth A. Hoge, Aparna Keshaviah
2013-01

Bipolar Mixed States: An International Society for Bipolar Disorders Task Force Report of Symptom Structure, Course of Illness, and Diagnosis

Beny Lafer, Jan Scott, Michael Bauer, Mark A Frye, Trisha Suppes, Giulio Perugi, Alan C Swann
2013-11-01

Atypical antipsychotics in the treatment of posttraumatic stress disorder
2013-11-01

The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

Heinz Grunze, Philip B. Mitchell, Tadafumi Kato, Gordon Parker, Eduard Vieta, Siegfried Kasper, Juan Undurraga, Beny Lafer, Francesc Colom, Anabel Martínez-Aran, Marc Valentí, David J. Bond, Ana González-Pinto, Georgios Demetrios Kotzalidis, Alessandro Serretti, Janusz Rybakowski, Boris Birmaher, Paolo Girardi, Hagop S. Akiskal, Terence A Ketter, Flávio Kapczinski, Robert L Findling, Eric Youngstrom, Joseph R Calabrese, Glenda MacQueen, Gin Malhi, Michael Bauer, Lori L. Altshuler, Susan L McElroy, Mark A Frye, Robert M. Post, Guy Goodwin, Willem A Nolen, Lakshmi N Yatham, Roy H Perlis, Carlos A Zarate, Allan H Young, Ross J. Baldessarini, Rasmus W Licht, Gary S Sachs, Mauricio Tohen, Michael E Thase, Seyyed Nassir Ghaemi, Giulio Perugi, Rif S El-Mallakh, Andrew Nierenberg, Charles L. Bowden, Isabella Pacchiarotti, Leonardo Tondo, Athanasios Koukopoulos, Konstantinos N Fountoulakis, Diego Hidalgo-Mazzei, Lorenzo Mazzarini, Carlos López-Jaramillo, Jean-Michel Azorin
2013-11-01

Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial

Carolyn Rodriguez, Jonathan D. Huppert, Monnica T. Williams, Mark B. Powers, Edna Foa, Carmen P McLean, Helen Blair Simpson, Shawn P Cahill, Donna Vermes, Chang-Gyu Hahn, Raphael Campeas
2013-07-25

Effects of medical comorbidity on anxiety treatment outcomes in primary care

Daniela Golinelli, Peter Roy-Byrne, Laura Campbell-Sills, Alexander Bystritsky, Michelle Craske, Greer Sullivan, Stacy Shaw Welch, Murray B. Stein, Cathy D Sherbourne, Ariel Lang, Denise A Chavira
2013-06-10

Who gets the most out of cognitive behavioral therapy for anxiety disorders? The role of treatment dose and patient engagement

Daniela Golinelli, Peter Roy-Byrne, Michelle Craske, Greer Sullivan, Murray B. Stein, Cathy D Sherbourne, Daniel E Glenn
2013-07-01

Antidepressant medication augmented with cognitive-behavioral therapy for generalized anxiety disorder in older adults

Julie Loebach Wetherell, Eric J Lenze
2013-04-01

Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence

David Camfield
2013-04-30

Meta-analysis: aerobic exercise for the treatment of anxiety disorders
2013-07-01

D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder

Stefan G. Hofmann, Jasper A Smits, Michael W. Otto, Alicia E Meuret
2013-01-16

D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia

Jasper A Smits, Michael W. Otto, Mark B. Powers, Stefan G. Hofmann, Michael J. Telch
2013-01-07

Exercise for anxiety disorders: systematic review
2013-08-13

Antidepressant tolerability in anxious and depressed youth at high risk for bipolar disorder: a prospective naturalistic treatment study

Jeffrey R Strawn, Melissa P DelBello
2013-09-01

A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan

Michael C Freed
2013-07-01

Mixed features of depression: why DSM-5 is wrong (and so was DSM-IV).

Gabriele Sani
2013-07-01

Psychodynamic therapy and cognitive-behavioral therapy in social anxiety disorder: a multicenter randomized controlled trial.

Bernhard Strauß, Falk Leichsenring, Peter Joraschky
2013-01-25

Randomized clinical trial of adapted mindfulness-based stress reduction versus group cognitive behavioral therapy for heterogeneous anxiety disorders.

Michelle Craske
2012-08-29

Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials

Siegfried Kasper, Markus Dold, Markus Dold, Rupert Lanzenberger
2012-05-01

Neurobiology of anxiety: from neural circuits to novel solutions?
2012-04-24

Course of comorbid anxiety disorders among adults with bipolar disorder in the U.S. population

Carlos Blanco, Benjamin I Goldstein
2012-02-21

Risks for the transition from major depressive disorder to bipolar disorder in the National Epidemiologic Survey on Alcohol and Related Conditions

Roy H Perlis
2012-12-05

The endocannabinoid system provides an avenue for evidence-based treatment development for PTSD.
2012-08-17

The mistaken claim of bipolar 'overdiagnosis': solving the false positives problem for DSM-5/ICD-11.
2012-06-22

Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study.

Dan J. Stein, Soraya Seedat, Sharain Suliman, Paul R Carey
2012-04-04

A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder

Rianne A de Kleine, Gert-Jan Hendriks, Theo G Broekman
2011-12-21

Management of treatment-resistant depression

Artikel - wd:Q26798229

Välkommen till Inventaire

din gemenskap och vänners bibliotek

lär mer